Multiple sclerosis
MS treatment, rehab and research.
- Multiple sclerosis23 Mar
Roche is testing its Floodlight MS app in the University of Essex Brain Research and Imaging Centre
- Multiple sclerosis10 Mar
Eating a ketogenic diet could help reduce fatigue and depression in people with MS and improve quality of life, a new study has suggested. The diet - which primarily consists of meat, fish, eggs, heavy cream, butter, oils and non-starchy vegetables like pea pods, carrots, broccoli and peppers - was shown to have potential benefits [...]
- Multiple sclerosis8 Mar
Research came after link established between higher MS rates in populations where a lot of cow's milk is consumed
- Multiple sclerosis7 Feb
The proton MR spectroscopy technique could lead to more effective diagnosis and treatment of multiple sclerosis
- Multiple sclerosis14 Jan
Tackling Epstein-Barr virus (EPV) - one of the most common viruses in humans - could lead to MS prevention, researchers say
- Multiple sclerosis21 Dec
Treatments used to help people with multiple sclerosis (MS) manage their condition can reduce the effectiveness of COVID-19 vaccines, a new study has found.
- Multiple sclerosis15 Dec
Exposure to sunshine for children and young adults may protect against multiple sclerosis (MS), new research has revealed.
- Multiple sclerosis18 Nov
Helius Medical Technologies is playing an increasingly central role in the growth of the neurostimulation market globally. Its PoNS device is changing the lives of MS patients in North America and helping to demonstrate the impact of non-invasive technology in neurological disorders. NR Times speaks to Helius’ CEO Dane Andreeff about its pioneering work
- Multiple sclerosis4 Oct
Two vital programmes to support people living with multiple sclerosis are broadening their reach in response to the increasing need from people with MS across the country, which has been exacerbated by the pandemic and the knock-on effect of a shortage of community resources and growing waiting lists.
- Multiple sclerosis10 Sep
An immunological molecule called fractalkine can boost the production of brain cells that produce myelin, a key factor in diseases such as MS, a study shows.













